Anzeige
Mehr »
Montag, 06.07.2026 - Börsentäglich über 12.000 News
8,8-Mio.-Nanocap direkt neben Europas Lithium-Giganten - jetzt steigt die Spannung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EGAA | ISIN: US5393193017 | Ticker-Symbol: 8640
NASDAQ
06.07.26 | 18:36
7,550 US-Dollar
+4,72 % +0,340
Branche
Elektrotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NOMAD POWER SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
NOMAD POWER SOLUTIONS INC 5-Tage-Chart

Aktuelle News zur NOMAD POWER SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:36LIXTE Biotechnology Holdings, Inc. Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD78-- New Corporate Identity Reflects Strategic Transition into AI Energy Infrastructure Equipment & Services Sector Following Acquisition of NOMAD Transportable Power Systems -- BOCA RATON, Fla., July...
► Artikel lesen
DoLIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report1
NOMAD POWER SOLUTIONS Aktie jetzt für 0€ handeln
DoLixte Biotechnology Holdings, Inc.: Lixte Completes Merger With Nomad Transportable Power Systems151-Transaction Transforms LIXTE to New Growth Sector Addressing Multi-Billion-Dollar Market of Mobile, Utility-Grade Battery Energy Storage Systems- -Company...
► Artikel lesen
26.06.LIXTE Biotechnology joins Russell Microcap Index1
26.06.LIXTE Biotechnology added to Russell Microcap Index effective today1
26.06.Lixte Biotechnology Holdings, Inc.: LIXTE Joins Russell Microcap Index1
18.06.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report1
18.06.LIXTE Biotechnology to loan $6.5M to NOMAD ahead of acquisition close2
18.06.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026978Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs - Combined Company to be Renamed NOMAD Power Solutions, Inc. and Trade Under a New Ticker Symbol BOCA...
► Artikel lesen
12.06.LIXTE Biotechnology sings deal to acquire 100% of NOMAD to meet grid demand2
12.06.Lixte Biotechnology to acquire NOMAD Power1
12.06.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)227Company to be Renamed NOMAD Power Solutions • First-to-Market with the Mobile, Utility-Grade 1 MW BESS • Addressing a Multi-Hundred-Billion-Dollar Power Capacity Opportunity BOCA RATON, Fla. & WATERBURY...
► Artikel lesen
03.06.LIXTE Biotechnology prices $16.6M registered direct offering1
03.06.Lixte Biotechnology raises $16.6 million in direct offering2
03.06.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth1
01.06.Lixte Biotechnology Shares Slip 6% Despite Pivot To AI Energy Infrastructure Business1
01.06.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report1
01.06.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors158Bringing More Than Three Decades of Energy Investment Experience, Mr. Porter Has Helped Build a Global Power Infrastructure Portfolio, Strengthening LIXTE's Strategic Expansion into AI Energy Infrastructure...
► Artikel lesen
14.05.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update200BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing...
► Artikel lesen
14.05.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 10-Q, Quarterly Report2
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1